Selected Anemia References
Bob Richard, 4-4-03
Iron
Andrews, N.C. 1999. Disorders of iron metabolism. N Engl J Med 341:1986-1995.
Cook, J.D., Flowers, C.H., and Skikne, B.S. 2003. The quantitative assessment of body
iron. Blood 9:9.
Faich G; Strobos J. Sodium ferric gluconate complex in sucrose: safer intravenous iron
therapy than iron dextrans Am J Kidney Dis 1999 Mar;33(3):464-70
Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis.
Blood. 2000 Aug 1;96(3):823-33.
Anemia of Chronic Disease
Papadaki HA, Kritikos HD, Valatas V, Boumpas DT, and Eliopoulos GD, Anemia of
chronic disease in rheumatoid arthritis is associated with increased apoptosis of
bone marrow erythroid cells: improvement following anti-tumor necrosis factoralpha antibody therapy. Blood 2002.
Pettersson, T., Kivivuori, S.M., and Siimes, M.A. 1994. Is serum transferrin receptor
useful for detecting iron-deficiency in anaemic patients with chronic
inflammatory diseases? Br J Rheumatol 33:740-744
Rimon, E., Levy, S., Sapir, A., Gelzer, G., Peled, R., Ergas, D., and Sthoeger, Z.M. 2002.
Diagnosis of iron deficiency anemia in the elderly by transferrin receptor-ferritin
index. Arch Intern Med 162:445-449.
Skikne, B.S., Flowers, C.H., and Cook, J.D. 1990. Serum transferrin receptor: a
quantitative measure of tissue iron deficiency. Blood 75:1870-1876
Erythropoietin
Barosi, G. 1994. Inadequate erythropoietin response to anemia: definition and clinical
relevance. Ann Hematol 68:215-223.
Cella, D., Zagari, M.J., Vandoros, C., Gagnon, D.D., Hurtz, H.J., and Nortier, J.W. 2003.
Epoetin alfa treatment results in clinically significant improvements in quality of
life in anemic cancer patients when referenced to the general population. J Clin
Oncol 21:366-373.
Crawford, J., Cella, D., Cleeland, C.S., Cremieux, P.Y., Demetri, G.D., Sarokhan, B.J.,
Slavin, M.B., and Glaspy, J.A. 2002. Relationship between changes in
hemoglobin level and quality of life during chemotherapy in anemic cancer
patients receiving epoetin alfa therapy. Cancer 95:888-895.
Miller, C.B., Jones, R.J., Piantadosi, S., Abeloff, M.D., and Spivak, J.L. 1990. Decreased
erythropoietin response in patients with the anemia of cancer. N Engl J Med
322:1689-1692.
Seidenfeld, J., Piper, M., Flamm, C., Hasselblad, V., Armitage, J.O., Bennett, C.L.,
Gordon, M.S., Lichtin, A.E., Wade, J.L., 3rd, Woolf, S., et al. 2001. Epoetin
treatment of anemia associated with cancer therapy: a systematic review and
meta-analysis of controlled clinical trials. J Natl Cancer Inst 93:1204-1214.
B12/Folate deficiency
Carmel, R, Karmaze DS, the deoxyuridine suppression test identifies sibtle cobalamin
deficiencies in patients with typical megaloblastic anemia. JAMA 253: 1284,
1985
Pruthi, R.K. and Tefferi A. Pernicious anemia revisited. Mayo Clin Proc 1994
Feb;69(2):144-50
Toh, BH, et al., Pernicious Anemia, NEJM, Vol 13: 337 (20), 1441-8